“civitas-therapeutics” Archives

in
Entry Author Date Location
Acorda Gets FDA Nod for New Parkinson’s Drug, But Rival Looms 12/24/18 New York
With Acorda Data, Experts Weigh the Benefits of New Parkinson’s Drugs 04/25/18 New York
Sunovion Parkinson’s Drug Heads to FDA, Setting Up Battle With Acorda 01/30/18 Boston
Acorda Scraps One Parkinson’s Drug, Puts Its Cash Behind Another 11/20/17 New York
FDA Refuses to Review Acorda Parkinson’s Drug, Shares Tumble 08/29/17 New York
Acorda Touts Success in Parkinson’s Drug Study, Awaits Safety Data 02/09/17 New York
Acorda Leans on Parkinson’s Drugs After Post-Stroke Study Fails 11/21/16 New York
Bio Roundup: RIP Roger Tsien, Novartis CAR-T Wheel, Zika News & More 09/02/16 National
Four Years After Neuronex Buyout, Acorda Dumps Epilepsy Drug 05/20/16 New York
Kala Pharma Nabs $68M, Crossover Backers for Eye Drug Push 04/13/16 Boston
East Coast Biotech Roundup: Alkermes, Zafgen, Snowmaggedon & More 01/22/16 Boston
Acorda Doubles Down on Parkinson, Buys Biotie For $363M 01/19/16 New York
Taris 2.0: A Year After Buyout, VCs Bet $32M More on a Second Strike 10/27/15 Boston
With $21M, Retooled Blend Whips up Mini-Smart Bombs For Cancer 01/07/15 Boston
East Coast Biotech Roundup: GliaCure, Civitas, T2, & More 09/29/14 Boston
Alkermes Spinoff Civitas, Poised for IPO, Sells to Acorda for $525M 09/24/14 Boston
Acorda Therapeutics Acquires Civitas Therapeutics for $525,000,000 09/24/14 Boston
East Coast Biotech Roundup: Biogen, Civitas, Rhythm, Alkermes, & More 08/29/14 Boston
Civitas Therapeutics Obtains $55,000,000 Series C Financing 08/25/14 Boston
East Coast Biotech Roundup: Concert, Merrimack, Vertex, & More 05/02/14 Boston
East Coast Life Sciences Roundup: Genocea, Biogen, OvaScience, & More 09/13/13 Boston
Civitas Scores $38M Series B For Parkinson’s Drug Push 09/11/13 Boston
East Coast Life Sciences Roundup: IPO Madness, Amicus, & More 06/21/13 Boston
Alkermes Spinout, Civitas, Nabs Second Grant From Fox Foundation 06/18/13 Boston
Startups Progress with Novel Drugs for Parkinson’s Disease 10/29/12 New York
The Boston Life Sciences Newsmakers: Civitas, Blend, Forma, & More 01/13/12 Boston
Civitas Charts Positive Data on Inhaled Parkinson’s Drug 01/06/12 Boston
Alkermes Spinoff, Civitas, Gets Michael J. Fox Support for Inhalable Parkinson’s Drug 11/29/11 Boston
Top 10 List of Boston-Area VC Deals for Q4 2010: NinePoint, 1366, Rive, and More 01/24/11 Boston
Rib-X Wrappes Up $20M, Oxford Closes $66M on Sixth Fund, Ocular Adds $6M, & More Boston-Area Life Sciences News 01/14/11 Boston
Page 1 of 2 next page »